What is Replimune Group's common stock?

Replimune Group (REPL) reported common stock of 150M in Q4 2025.

How has Replimune Group's common stock changed year-over-year?

Replimune Group's common stock decreased by 0.0% year-over-year, from 150M to 150M.

What is the long-term trend for Replimune Group's common stock?

Over 4 years (2021 to 2025), Replimune Group's common stock has grown at a 651.6% compound annual growth rate (CAGR), from 47K to 150M.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Replimune Group REPL Common Stock

Common Stock at other companies

AmgenAMGN

2.8B0.0%

Inhibrx Biosciences, Inc.INBX

120M0.0%

ImmunomeIMNM

$11K+22.2%

CG OncologyCGON

$9K+12.5%

Erasca, Inc.ERAS

$31K+10.7%

Relay Therapeutics, Inc.RLAY

$182K+8.3%

Other financials

Income statement

See full

Operating income-$71.9M-8.9%

Net income-$70.9M-6.9%

EPS (diluted)-$0.77+2.5%

Balance sheet

See full

Cash & equivalents$124.7M-28.3%

Total debt$79.2M+0.5%

Total equity$210.5M-56.4%

Total assets$333.6M-44.7%

Cash flow

See full

Operating cash flow-$66.0M-30.1%

CapEx$135.0K-92.5%

Free cash flow-$66.1M-25.9%

Valuation

See full

Market cap$930.59M+30.2%

Enterprise value$885.15M+30.0%

Returns & leverage

See full

Return on equity-90.9%+362pp

Debt / equity0.4×+0.2×

Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Replimune Group's common stock?: Replimune Group (REPL) reported common stock of 150M in Q4 2025.
How has Replimune Group's common stock changed year-over-year?: Replimune Group's common stock decreased by 0.0% year-over-year, from 150M to 150M.
What is the long-term trend for Replimune Group's common stock?: Over 4 years (2021 to 2025), Replimune Group's common stock has grown at a 651.6% compound annual growth rate (CAGR), from 47K to 150M.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).